HIV診斷檢驗的市場規模、佔有率、展望、機會 (2022年～2030年):檢驗類型、各地區

HIV Diagnostics Test Market, by Test type and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年06月17日 | 出版商:

Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

HIV感染疾病的全球增加促進在預測期間內的HIV診斷檢驗市場成長。

本報告提供全球HIV診斷檢驗的市場調查，市場定義和概要，市場成長的各種影響因素分析，法律規章、償付環境，市場規模的變化、預測，各種區分、各地區/主要國家的明細，競爭環境，主要企業簡介等彙整資訊。

Human immunodeficiency virus (HIV) is an infection that attacks the body's immune system, specifically the white blood cells called CD4 cells. HIV destroys these CD4 cells, weakening a person's immunity against opportunistic infections, such as tuberculosis and fungal infections, severe bacterial infections and some cancers. The World Health Organization (WHO) recommends that every person who may be at risk of HIV should access testing. People at increased risk of acquiring HIV should seek comprehensive and effective HIV prevention, testing and treatment services. HIV diagnostics plays a major role in HIV prevention, treatment, care, and other support services. The diagnosis of HIV include testing services in health-care facilities, and wide range of community-based approaches along with HIV self-testing.

Market Dynamics

The increasing prevalence of HIV infections globally is expected to drive the market growth in the forecast period. For instance, according to the Pan American Health Organization (PAHO): 2020, the number of HIV infections increased by 21% from 2010 and 2019 in Latin America. According to the same source, the number of annual new infections continued to rise, reaching 120,000 in 2019. According to UNAIDS: AIDSinfo: 2018, in India, around 2.1 million people were suffering from HIV during 2017, making it the third-largest HIV epidemic in the world. Furthermore, as per UNAIDS: 2017; India's HIV epidemic had slowed down, as HIV infections declined by 27% and AIDS-related deaths reduced by more than 56% between 2010 and 2017. However, in 2017, new infections increased to 88,000 from 80,000 and AIDS-related deaths increased to 69,000 from 62,000, from the year 2010, in India.

Key features of the study:

This report provides an in-depth analysis of the global HIV diagnostics test market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global HIV diagnostics test market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include Abbott, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol -Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global HIV diagnostics test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HIV diagnostics test market

Detailed Segmentation:

Global HIV Diagnostics Test Market, By Test Type:
- Screening
  - Third Generation (Antibody Test)
  - Laboratory-based
  - Point-of-Care
  - Fourth Generation (Antibody Test)
  - Laboratory-based
  - Point-of-Care
  - Others
- Differentiation & Confirmation Test
- Monitoring Test
  - CD4 Test
  - Viral Load Tests
Global HIV Diagnostics Test Market, By Region:
- North America
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Country
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Country/Region
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Abbott
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bio-Rad Laboratories, Inc.
- Hologic, Inc.
- Siemens Healthineers
- Roche AG
- Beckman Coulter Inc.
- OraSure Technologies, Inc.
- Becton, Dickinson and Company
- Merck KGaA
- Chembio Diagnostic Systems, Inc.
- Zyomyx Incorporation
- Bristol -Myers Squibb
- Janssen Pharmaceutica NV
- QIAGEN N.V.
- ViiV Healthcare Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Region
- Market Opportunity Map

3. Global HIV Diagnostics Test Market Insights

Drivers
Restraints
Opportunity
Impact Analysis
Market Trends
Key Highlights
Regulatory Scenario
Reimbursement Scenario
PEST Analysis
PORTER's Analysis
Recent Product Launch
Merger and Acquisition Scenario

4. Global HIV Diagnostics Test Market- COVID-19 Impact Analysis

COVID-19 Epidemiology
Economic Impact
Overall Impact on Healthcare

5. Global HIV Diagnostics Test Market, By Test Type, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
- Third Generation (Antibody Test)
- Laboratory-based
- Point-of-Care
- Fourth Generation (Antibody Test)
- Laboratory-based
- Point-of-Care
- Others
Differentiation & Confirmation Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Monitoring Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
- CD4 Test
- Viral Load Tests

6. Global HIV Diagnostics Test Market, By Region, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Region at Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2017-2030, (US$ Million)
- South Africa
- Central Africa
- North Africa

7. Company Profiles

Abbott*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Roche AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Beckman Coulter Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
OraSure Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chembio Diagnostic Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zyomyx Incorporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bristol -Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Janssen Pharmaceutica NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ViiV Healthcare Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies